BP

Bijulal Prabhakaran Nair Nandini

Active Director Managing Director DIN 11617895
DIN 11617895 First appointment Mar 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Bijulal Prabhakaran Nair Nandini

Data last updated:

Bijulal Prabhakaran Nair Nandini is a Managing Director at Jb Pharmahub Private Limited (since 2026). The company operates in Pharma.

DIN 11617895
Primary Designation Managing Director
Industry Pharma
First Appointment 19 Mar 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jb Pharmahub Private Limited U47721KL2026PTC101895
Managing Director19 Mar 20262026Active

Board colleagues of Bijulal Prabhakaran Nair Nandini

NameDINCompanyDesignation
John Tharakan11617896Jb Pharmahub Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Jb Pharmahub Private Limited
Premium access

Shareholding and investment profile for Bijulal Prabhakaran Nair Nandini

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bijulal Prabhakaran Nair Nandini

Bijulal Prabhakaran Nair Nandini currently holds 1 directorship: Jb Pharmahub Private Limited (Managing Director, since 19 Mar 2026).

Bijulal Prabhakaran Nair Nandini was first appointed on 19 Mar 2026 as Managing Director at Jb Pharmahub Private Limited.

The current boards of Bijulal Prabhakaran Nair Nandini's companies include John Tharakan (Jb Pharmahub Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available